XP
State Street SPDR S&P Pharmaceuticals ETF (XPH)
NYSE_ARCA·Financial Services·Asset Management
$60.39
+1.04%
Mkt Cap $221.97M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$241.50
Range $163.80 – $283.50
Implied Upside
+299.9%
Consensus $241.50 vs current $60.39